Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice
- PMID: 19920059
- DOI: 10.1093/annonc/mdp538
Second-line treatments of advanced non-small-cell lung cancer: new evidence for clinical practice
Comment on
-
Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel.Ann Oncol. 2009 Sep;20(9):1483-1488. doi: 10.1093/annonc/mdp031. Epub 2009 Mar 12. Ann Oncol. 2009. PMID: 19282468 Clinical Trial.
-
Gefitinib for advanced non-small-cell lung cancer and quality of life: expanding and improving treatment options.Ann Oncol. 2009 Sep;20(9):1455-1457. doi: 10.1093/annonc/mdp387. Ann Oncol. 2009. PMID: 19704160 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
